Moderna (MRNA) Tops Q3 EPS by $1.54

Moderna (NASDAQ: MRNA) reported Q3 EPS of ($0.51), $1.54 better than the analyst estimate of ($2.05). Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $909.97 million.

GUIDANCE:

Moderna sees FY2025 revenue of $1.6-2 billion, versus the consensus of $1.88 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• China retail sales growth slows to 0.6% in July, Macquarie comments
• Active options: NVDA TSLA MU SPCX AAPL AMZN MSFT META INTC